Advancements in assistance from artificial intelligence include ambient listening to take notes during physician and patient conversations.
Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.
Investigators compared these outcomes due to limited research in the space, with previous surveys suggesting care disparities.
Waibel shared pearls in laser therapy and other scar treatment modalities in her talks at the American Academy of Dermatology Annual Meeting.
A matching-adjusted indirect comparison found that some patients with PsA are more likely to achieve long-term treatment outcomes with bimekizumab.
The survey conducted by Almirall included participants in the US and Europe.
Pulsed dye lasers are now being used for several different dermatologic conditions.
The key opinion leaders examine a case study of a 42-year-old male patient, detailing the process of treatment selection and shared decision-making that led to improved outcomes.
There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.
Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
The WHO underscores the significance of addressing scabies as a neglected skin disease, especially in regions with limited health care access.
Hair loss affects self-esteem and feelings of well-being, but exciting treatments are on the horizon.
Clinicians, especially those who see patients with inflammatory and pigmentary disorders, should incorporate alcohol use disorder screening measures into all patient visits.
Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with dermatologic conditions, emphasizing the importance of comprehensive medication reviews, patient-centered decision-making, and the need for including pregnant patients in clinical trials.
A 5-expert panel continues their conversation on atopic dermatitis, discussing patient-centered care and key takeaways.
Miller is presenting 3 sessions at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.
An expert in the management of skin conditions provides an overview of a 20-year-old male diagnosed with atopic dermatitis, discussing key insights from a round table discussion. The conversation focused on effective management strategies, best practices for prior authorization approvals, and the significance of treatment vehicles.
John Strasswimmer, MD, PhD comments on the impressive utility of both vismodegib and sonidegib in patients with advanced basal cell carcinoma and Jonathan S Zager, MD, FACS, FSSO provides his insight into the clinical utility of both of these treatments.
Social media is fraught with misinformation. Pharmacists play a key role in breaking through the fallacies with facts and education on skin care.
What we know about monkeypox in pregnancy, including treatment recommendations, vaccination, and postpartum care.
Researchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.
The key opinion leaders examine a case study of a 42-year-old male patient, detailing the process of treatment selection and shared decision-making that led to improved outcomes.
Tirbanibulin (Klisyri, Almirall) has been approved by the U.S. Food and Drug Administration (FDA) for the topical treatment of actinic keratosis on the face or scalp.
There are barriers to telehealth adoption that physicians must overcome to realize the technology’s promise.